An aberrant immune-epithelial progenitor niche drives viral lung sequelae.

Journal

Nature

ISSN: 1476-4687

Titre abrégé: Nature

Pays: England

ID NLM: 0410462

Informations de publication

Date de publication:
04 Sep 2024

Historique:

received: 09 11 2023

accepted: 08 08 2024

medline: 5 9 2024

pubmed: 5 9 2024

entrez: 4 9 2024

Statut: aheadofprint

Résumé

The long-term physiological consequences of respiratory viral infections, particularly in the aftermath of the COVID-19 pandemic-termed post-acute sequelae of SARS-CoV-2 (PASC)-are rapidly evolving into a major public health concern

Identifiants

DOI: 10.1038/s41586-024-07926-8 PMID: 39232171

pubmed: 39232171

doi: 10.1038/s41586-024-07926-8

pii: 10.1038/s41586-024-07926-8

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Informations de copyright

Références

Nalbandian, A. et al. Post-acute COVID-19 syndrome. Nat. Med. 27, 601–615 (2021).

pubmed: 33753937 pmcid: 8893149 doi: 10.1038/s41591-021-01283-z

Choutka, J., Jansari, V., Hornig, M. & Iwasaki, A. Unexplained post-acute infection syndromes. Nat. Med. 28, 911–923 (2022).

pubmed: 35585196 doi: 10.1038/s41591-022-01810-6

Narasimhan, H., Wu, Y., Goplen, N. P. & Sun, J. Immune determinants of chronic sequelae after respiratory viral infection. Sci. Immunol. 7, eabm7996 (2022).

pubmed: 35857581 doi: 10.1126/sciimmunol.abm7996

Cheon, I. S. et al. Immune signatures underlying post-acute COVID-19 lung sequelae. Sci. Immunol. 6, eabk1741 (2021).

pubmed: 34591653 pmcid: 8763087 doi: 10.1126/sciimmunol.abk1741

Vijayakumar, B. et al. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity 55, 542–556 (2022).

pubmed: 35151371 pmcid: 8789571 doi: 10.1016/j.immuni.2022.01.017

Phetsouphanh, C. et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 23, 210–216 (2022).

pubmed: 35027728 doi: 10.1038/s41590-021-01113-x

Jyothula, S. S. K. et al. Fulminant lung fibrosis in non-resolvable COVID-19 requiring transplantation. eBioMedicine 86, 104351 (2022).

pubmed: 36375315 pmcid: 9667270 doi: 10.1016/j.ebiom.2022.104351

Gagiannis, D. et al. Clinical, imaging, and histopathological features of pulmonary sequelae after mild COVID-19. Am. J. Respir. Crit. Care Med. 208, 618–621 (2023).

pubmed: 37315323 pmcid: 10492248 doi: 10.1164/rccm.202302-0285LE

Yao, C. et al. Maladaptive TGF-β signals to the alveolar epithelium drive fibrosis after COVID-19 infection. Am. J. Respir. Crit. Care Med. 208, 201–204 (2023).

pubmed: 37236627 pmcid: 10395488 doi: 10.1164/rccm.202302-0264LE

Xie, Y., Choi, T. & Al-Aly, Z. Association of treatment with nirmatrelvir and the risk of post–COVID-19 condition. JAMA Intern. Med. 183, 554–564 (2023).

pubmed: 36951829 pmcid: 10037200 doi: 10.1001/jamainternmed.2023.0743

Al-Aly, Z., Xie, Y. & Bowe, B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594, 259–264 (2021).

pubmed: 33887749 doi: 10.1038/s41586-021-03553-9

Bharat, A. et al. Lung transplantation for patients with severe COVID-19. Sci. Transl. Med. 12, eabe4282 (2020).

pubmed: 33257409 pmcid: 8050952 doi: 10.1126/scitranslmed.abe4282

Stewart, I. et al. Residual lung abnormalities after COVID-19 hospitalization: interim analysis of the UKILD Post-COVID-19 Study. Am. J. Respir. Crit. Care Med. 207, 693–703 (2022).

pmcid: 10037479 doi: 10.1164/rccm.202203-0564OC

Bowe, B., Xie, Y. & Al-Aly, Z. Postacute sequelae of COVID-19 at 2 years. Nat. Med. 29, 2347–2357 (2023).

Merad, M., Blish, C. A., Sallusto, F. & Iwasaki, A. The immunology and immunopathology of COVID-19. Science 375, 1122–1127 (2022).

pubmed: 35271343 doi: 10.1126/science.abm8108

Bingham, G. C. et al. High-dimensional comparison of monocytes and T cells in post-COVID and idiopathic pulmonary fibrosis. Front. Immunol. 14, 1308594 (2024).

pubmed: 38292490 pmcid: 10824838 doi: 10.3389/fimmu.2023.1308594

Arish, M., Qian, W., Narasimhan, H. & Sun, J. COVID-19 immunopathology: from acute diseases to chronic sequelae. J. Med. Virol. 95, e28122 (2023).

pubmed: 36056655 doi: 10.1002/jmv.28122

Klein, J. et al. Distinguishing features of long COVID identified through immune profiling. Nature 623, 139–148 (2023).

pubmed: 37748514 pmcid: 10620090 doi: 10.1038/s41586-023-06651-y

Vaughan, A. E. et al. Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury. Nature 517, 621–625 (2015).

pubmed: 25533958 doi: 10.1038/nature14112

Kobayashi, Y. et al. Persistence of a regeneration-associated, transitional alveolar epithelial cell state in pulmonary fibrosis. Nat. Cell Biol. 22, 934–946 (2020).

pubmed: 32661339 pmcid: 7461628 doi: 10.1038/s41556-020-0542-8

Strunz, M. et al. Alveolar regeneration through a Krt8

pubmed: 32678092 pmcid: 7366678 doi: 10.1038/s41467-020-17358-3

Choi, J. et al. Inflammatory signals induce AT2 cell-derived damage-associated transient progenitors that mediate alveolar regeneration. Cell Stem Cell 27, 366–82 (2020).

pubmed: 32750316 pmcid: 7487779 doi: 10.1016/j.stem.2020.06.020

Kumar, P. A. et al. Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell 147, 525–538 (2011).

pubmed: 22036562 pmcid: 4040224 doi: 10.1016/j.cell.2011.10.001

Xie, T. et al. Abnormal respiratory progenitors in fibrotic lung injury. Stem Cell Res. Ther. 13, 64 (2022).

pubmed: 35130980 pmcid: 8822870 doi: 10.1186/s13287-022-02737-y

Habermann, A. C. et al. Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis. Sci. Adv. 6, eaba1972 (2020).

pubmed: 32832598 pmcid: 7439444 doi: 10.1126/sciadv.aba1972

Adams, T. S. et al. Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis. Sci. Adv. 6, eaba1983 (2020).

pubmed: 32832599 pmcid: 7439502 doi: 10.1126/sciadv.aba1983

Rendeiro, A. F. et al. Persistent alveolar type 2 dysfunction and lung structural derangement in post-acute COVID-19. Preprint at medRxiv https://doi.org/10.1101/2022.11.28.22282811 (2022).

Jiang, P. et al. Ineffectual type 2-to-type 1 alveolar epithelial cell differentiation in idiopathic pulmonary fibrosis: persistence of the KRT8

pubmed: 32073903 pmcid: 7258651 doi: 10.1164/rccm.201909-1726LE

Tsukui, T. et al. Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis. Nat. Commun. 11, 1920 (2020).

pubmed: 32317643 pmcid: 7174390 doi: 10.1038/s41467-020-15647-5

Leist, S. R. et al. A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice. Cell 183, 1070–1085 (2020).

pubmed: 33031744 pmcid: 7510428 doi: 10.1016/j.cell.2020.09.050

Dinnon, K. H. et al. SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice. Sci. Transl. Med. 14, eabo5070 (2022).

pubmed: 35857635 doi: 10.1126/scitranslmed.abo5070

Goplen, N. P. et al. Tissue-resident CD8

pubmed: 33158975 pmcid: 7970412 doi: 10.1126/sciimmunol.abc4557

Dinnon, K. H. et al. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature 586, 560–566 (2020).

pubmed: 32854108 pmcid: 8034761 doi: 10.1038/s41586-020-2708-8

Winkler, E. S. et al. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat. Immunol. 21, 1327–1335 (2020).

pubmed: 32839612 pmcid: 7578095 doi: 10.1038/s41590-020-0778-2

Wei, X., Narasimhan, H., Zhu, B. & Sun, J. Host recovery from respiratory viral infection. Ann. Rev. Immunol. 41, 277–300 (2023).

doi: 10.1146/annurev-immunol-101921-040450

Wang, F. et al. Regulation of epithelial transitional states in murine and human pulmonary fibrosis. J. Clin. Invest. 133, e165612 (2023).

Liang, J. et al. Reciprocal interactions between alveolar progenitor dysfunction and aging promote lung fibrosis. eLife 12, e85415 (2023).

pubmed: 37314162 pmcid: 10292844 doi: 10.7554/eLife.85415

D’Agnillo, F. et al. Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19. Sci. Transl. Med. 13, eabj7790 (2021).

Melms, J. C. et al. A molecular single-cell lung atlas of lethal COVID-19. Nature 595, 114–119 (2021).

pubmed: 33915568 pmcid: 8814825 doi: 10.1038/s41586-021-03569-1

Konkimalla, A. et al. Transitional cell states sculpt tissue topology during lung regeneration. Cell Stem Cell 30, 1486–502 (2023).

pubmed: 37922879 doi: 10.1016/j.stem.2023.10.001

Fiege, J. K. & Langlois, R. A. Investigating influenza A virus infection: tools to track infection and limit tropism. J. Virol. 89, 6167–6170 (2015).

pubmed: 25855737 pmcid: 4474293 doi: 10.1128/JVI.00462-15

Katsura, H., Kobayashi, Y., Tata, P. R. & Hogan, B. L. M. IL-1 and TNFα contribute to the inflammatory niche to enhance alveolar regeneration. Stem Cell Rep. 12, 657–666 (2019).

doi: 10.1016/j.stemcr.2019.02.013

Kostura, M. J. et al. Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc. Natl Acad. Sci. USA 86, 5227–5231 (1989).

pubmed: 2787508 pmcid: 297594 doi: 10.1073/pnas.86.14.5227

Littlefield, K. M. et al. SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog. 18, e1010359 (2022).

pubmed: 35617421 pmcid: 9176759 doi: 10.1371/journal.ppat.1010359

Krishna, B. A. et al. Spontaneous, persistent, T cell-dependent IFN-γ release in patients who progress to long COVID. Sci. Adv. 10, eadi9379 (2024).

Riemondy, K. A. et al. Single cell RNA sequencing identifies TGFβ as a key regenerative cue following LPS-induced lung injury. JCI Insight 5, e123637 (2019).

pubmed: 30913038 doi: 10.1172/jci.insight.123637

Nabhan, A. N., Brownfield, D. G., Harbury, P. B., Krasnow, M. A. & Desai, T. J. Single-cell Wnt signaling niches maintain stemness of alveolar type 2 cells. Science 359, 1118–1123 (2018).

pubmed: 29420258 pmcid: 5997265 doi: 10.1126/science.aam6603

Salama, C. et al. Tocilizumab in patients hospitalized with COVID-19 pneumonia. N. Engl. J. Med. 384, 20–30 (2020).

pubmed: 33332779 doi: 10.1056/NEJMoa2030340

Stancil, I. T. et al. Interleukin-6-dependent epithelial fluidization initiates fibrotic lung remodeling. Sci. Transl. Med. 14, eabo5254 (2022).

pubmed: 35857823 pmcid: 9981332 doi: 10.1126/scitranslmed.abo5254

Choi, J. et al. Release of Notch activity coordinated by IL-1β signalling confers differentiation plasticity of airway progenitors via Fosl2 during alveolar regeneration. Nat. Cell Biol. 23, 953–966 (2021).

pubmed: 34475534 pmcid: 7611842 doi: 10.1038/s41556-021-00742-6

Chen, B., Julg, B., Mohandas, S., Bradfute, S. B. & Force RMPT. Viral persistence, reactivation, and mechanisms of long COVID. eLife 12, e86015 (2023).

pubmed: 37140960 pmcid: 10159620 doi: 10.7554/eLife.86015

Proal, A. D. et al. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC). Nat. Immunol. 24, 1616–1627 (2023).

An EUA for baricitinib (olumiant) for COVID-19. Med. Lett. Drugs Ther. 62, 202–203 (2020).

An EUA for anakinra (kineret) for COVID-19. Med. Lett. Drugs Ther. 64, e203 (2022).

Goplen, N. et al. Combined sensitization of mice to extracts of dust mite, ragweed, and Aspergillus species breaks through tolerance and establishes chronic features of asthma. J. Allerg. Clin. Immunol. 123, 925–932 (2009).

doi: 10.1016/j.jaci.2009.02.009

Major, J. et al. Endothelial AHR activity prevents lung barrier disruption in viral infection. Nature 621, 813–820 (2023).

Weiner, A. I. et al. ΔNp63 drives dysplastic alveolar remodeling and restricts epithelial plasticity upon severe lung injury. Cell Rep. 41, 111805 (2022).

pubmed: 36516758 pmcid: 9808897 doi: 10.1016/j.celrep.2022.111805

Huang, S. et al. PPAR-γ in macrophages limits pulmonary inflammation and promotes host recovery following respiratory viral infection. J. Virol. 93, e00030-19 (2019).

pubmed: 30787149 pmcid: 6475778 doi: 10.1128/JVI.00030-19

Hübner, R. H. et al. Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques. 44, 507–511 (2008).

pubmed: 18476815 doi: 10.2144/000112729

Wong, L.-Y. R. et al. Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19. Nature 605, 146–151 (2022).

pubmed: 35314834 pmcid: 9783543 doi: 10.1038/s41586-022-04630-3

Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).

pubmed: 29203879 pmcid: 5715110 doi: 10.1038/s41598-017-17204-5